Prevalence of metabolic syndrome and diabetes mellitus type-2 and their association with intake of dairy and legume in Andean communities of Ecuador.

Autor: Manuel E Baldeón, Camilo Felix, Marco Fornasini, Federico Zertuche, Carolina Largo, María José Paucar, Liz Ponce, Sumathy Rangarajan, Salim Yusuf, Patricio López-Jaramillo

Publikováno v: PLoS ONE, Vol 16, Iss 7, p e0254812 (2021)

Metabolic syndrome (MetS) and type 2 diabetes (T2D) are metabolic alterations associated with high morbidity and mortality, particularly in low and middle-income countries. Diet has a significant impact on the risk to develop MetS and T2D; in this re

Externí odkaz: https://doaj.org/article/4c99b690e3a3450e96304b68da69a58a

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

Autor: Stephane Ederhy, Gilmar Reis, Andrzej Rynkiewicz, Keith Fox, Luca Padua, Helene ABERGEL, Andrew Murphy, Andrzej Szuba, YAN CARLOS DUARTE VERA, Pawel Maga, Scott Berkowitz, Roxana Buzas, Alexey Repin, Gregory Ducrocq, Olga Barbarash, Anton Sadomov, Grzegorz Gajos, Miguel Urina, David McEneaney, Richard Tytus, Dmitriy Panov, Angelika Chachaj, Weimar Kunz Sebba Barroso Souza, Akihiko Takahashi, Salim Yusuf, Mpiko Ntsekhe, Elena Gromova, David Halon, Richard Cheng, Marcello Galvani, Rohan Poulter, JUAN PABLO YEPEZ ALVARAN, Sara Doimo, Kim Houlind, Marcelo Arruda Nakazone, Avinainder Singh, Fabrice Martens, Aldo Pietro Maggioni, Fredrik Folke, Miroslav Brtko, Peter Verhamme, Laszlo Koranyi, Bart Meuris, ALVARO AVEZUM, Boris Vesga, Cyrille Boulogne, Peter Sinnaeve, Zhanna Sizova, Marianna Janion, Crina Julieta Sinescu, Laurent BERTOLETTI, Susanne Brenner, Jaroslav Hlubocký, ELENA BOBESCU, Michelle Canavan, Kamil Bury, Elena Nalesnik, Robert Mikulik, Yaroslav Malynovsky, Liudmyla Parkhomenko, Andrea Barbieri, Philippe Gabriel STEG, Kelley Branch, Olga Shestakovska, Jan Fedacko, Khairul Shafiq Ibrahim, Nicolae-Dan Tesloianu, Daniel Pella, Paul Fedak, Pavel Kaplan, Shirley Jansen, Martin O'Donnell, Marlena Broncel, Fernando Lanas, Stefan Störk, Natalia Garganeeva, Heyman Luckraz, CARLOS AUGUSTO CELEMIN FLOREZ, Larysa Mishchenko, Amos Katz, Jaroslava Paulasova Schwabova, Patricio Lopez-Jaramillo, Gustavo Aroca, Monika Możdżan, Zoltan Varallyay, María José Paucar, Tim Ramsay, Fernando Botto, Muhammad Imran Abdul Hafidz, Juan Esteban Gómez-Mesa, Kaijian Hou, Miroslav Spacek, Tomasz Guzik, Diego Rizzotti, Jackie Bosch, Shrikant Bangdiwala, Robert Welsh, Vojtěch Novotný, Andriy Bazylevych, Niall Mahon, Serhii Serik, Irina PARVU, Daniel Turek, Laurent Feldman, Dmitry Zateyshchikov, Mykola Bychkov, Yury Vasyuk, Camilo Felix, James Cotton, DHAYRA KAREM BARRETO, Sergey Kozhukhov, Sergio Zimmermann, Whady Hueb

Publikováno v: Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S & COMPASS Investigators 2017, ' Rivaroxaban with or without aspirin in stable cardiovascular disease ', New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (14), pp.1319-1330. ⟨10.1056/NEJMoa1709118⟩
Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A K, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S, COMPASS Investigators & Houlind, K C 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
New England journal of medicine, 377(14), 1319-1330. Massachussetts Medical Society
COMPASS Investigators 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118

BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention.METHODS: In this double-blind trial, we randomly assigned 27,395 participants with st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243f6667b35032565cd28a281ef18ebe
https://doi.org/10.1056/nejmoa1709118